- 2023 - 2027 Basic Research for Elucidating and Overcoming the Mechanisms of Progression of Early-Stage Lung Adenocarcinoma
- 2022 - 2025 EGFR変異肺癌に対する第4世代EGFR-TKIの有用性とその獲得耐性機序の解明
- 2022 - 2025 Targeted therapy for the patient with KRAS mutant lung cancer
- 2019 - 2022 Development of a new treatment strategy for HER2-alterated lung cancer
- 2018 - 2021 Exploration of predictive molecular biomarkers for acquired resistance mechanisms to EGFR tyrosine kinase inhibitors
- 2016 - 2019 Molecular targeted therapy against adenocarcinoma of the lung harboring MET exon 14 skipping mutation
- 2015 - 2016 肺癌における薬剤耐性因子のheterogenietyとその克服
- 2013 - 2015 Analysis of acquired resistance mechanisms to next-generation kinase inhibitors in lung cancers with EGFR mutation.
- 2012 - 2014 EGFR変異肺癌のキナーゼ阻害剤耐性機序の解明とその克服に向けた新規治療への展開
Show all